메뉴 건너뛰기




Volumn 61, Issue 3, 2009, Pages 331-337

Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products

Author keywords

Bioequivalence; Biopharmaceutics Classification System (BCS); Biowaiver; Doxycycline hyclate; US FDA guidance; WHO guidance

Indexed keywords

ANTODOX; DOXY WOLFF; DOXYCYCLIN AL; DOXYCYCLIN STADA; DOXYCYCLINE HYCLATE; PANCREATIN; UNCLASSIFIED DRUG; DOXYCYCLINE; DRUG DERIVATIVE; GELATIN;

EID: 85047684799     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.03.0007     Document Type: Article
Times cited : (6)

References (17)
  • 1
    • 53549113382 scopus 로고    scopus 로고
    • Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms
    • WHO, Geneva: World Health Organization
    • WHO. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms. Annex 8 of WHO Expert Committee on Specifications for Pharmaceutical Preparations. Geneva: World Health Organization, 2006.
    • (2006) Annex 8 of WHO Expert Committee on Specifications for Pharmaceutical Preparations
  • 3
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon GL et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-420.
    • (1995) Pharm Res , vol.12 , pp. 413-420
    • Amidon, G.L.1
  • 4
    • 3843097202 scopus 로고    scopus 로고
    • Classification of orally administered drugs on the World Health Organization Model List of Essential Medicines according to the biopharmaceutics classification system
    • Lindenberg M et al. Classification of orally administered drugs on the World Health Organization Model List of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004; 58: 265-278.
    • (2004) Eur J Pharm Biopharm , vol.58 , pp. 265-278
    • Lindenberg, M.1
  • 7
    • 3242751977 scopus 로고    scopus 로고
    • Comparative bioavailability study of doxycycline hyclate (equivalent to 100 mg doxycycline) capsules (doxycin vs vibramycin) for bioequivalence evaluation in healthy adult volunteers
    • Alsarra IA et al. Comparative bioavailability study of doxycycline hyclate (equivalent to 100 mg doxycycline) capsules (doxycin vs vibramycin) for bioequivalence evaluation in healthy adult volunteers. Int J Clin Pharmacol Ther 42: 2004; 373-377.
    • (2004) Int J Clin Pharmacol Ther , vol.42 , pp. 373-377
    • Alsarra, I.A.1
  • 9
    • 74849101124 scopus 로고    scopus 로고
    • Fachinformation Antodox 100 mg/200 mg Hartkapseln
    • Juta Pharma GmbH
    • Juta. Fachinformation Antodox 100 mg/200 mg Hartkapseln. Flensburg: Juta Pharma GmbH, 2007.
    • (2007) Flensburg
    • Juta1
  • 10
    • 74849128120 scopus 로고    scopus 로고
    • Aliud. Bioverfügbarkeit Doxycyclin AL. Laichingen: Aliud GmbH & Co. KG, 1988.
    • Aliud. Bioverfügbarkeit Doxycyclin AL. Laichingen: Aliud GmbH & Co. KG, 1988.
  • 11
    • 74849111337 scopus 로고    scopus 로고
    • Frankfurt/ Main: Dr Wolff Arzneimittel GmbH & Co. KG, Rote Liste Service GmbH
    • Wolff. Fachinformation Doxy-Wolff 100/200 mg. Frankfurt/ Main: Dr Wolff Arzneimittel GmbH & Co. KG, Rote Liste Service GmbH, 2006.
    • (2006) Fachinformation Doxy-Wolff 100/200 mg
    • Wolff1
  • 13
    • 74849121889 scopus 로고    scopus 로고
    • USP 29, Rockville: United States Pharmacopeial Convention Inc
    • USP 29. The United States Pharmacopeia (USP 29). Rockville: United States Pharmacopeial Convention Inc., 2006.
    • (2006) The United States Pharmacopeia (USP 29)
  • 14
    • 44749083713 scopus 로고    scopus 로고
    • WHO, 4th edn. Geneva: World Health Organization
    • WHO. The International Pharmacopoeia, 4th edn. Geneva: World Health Organization, 2006.
    • (2006) The International Pharmacopoeia
  • 15
    • 44749087279 scopus 로고    scopus 로고
    • Dissolution media simulating conditions in the proximal human gastrointestinal tract: An update
    • Jantratid E et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 2008; 25: 1663-1676.
    • (2008) Pharm Res , vol.25 , pp. 1663-1676
    • Jantratid, E.1
  • 16
    • 74849085961 scopus 로고    scopus 로고
    • JP 15. The Japanese Pharmacopoeia, 15th edn. Tokyo: Ministry of Health, Labour and Welfare, 2006.
    • JP 15. The Japanese Pharmacopoeia, 15th edn. Tokyo: Ministry of Health, Labour and Welfare, 2006.
  • 17
    • 74849095074 scopus 로고    scopus 로고
    • Ph. Eur. 6.0. European Pharmacopoeia 6.0. Straßburg: European Directorate for the Quality of Medicines, 2007.
    • Ph. Eur. 6.0. European Pharmacopoeia 6.0. Straßburg: European Directorate for the Quality of Medicines, 2007.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.